Advancing Diabetes Research Through Data-Driven Insights

Syntactiq responsibly accelerates innovation in diabetes care by providing and transforming patient data into actionable research insights using our AI-powered analytics platform.

1M+ days

Patient Data

Comprehensive patient data collected across multiple metrics and devices, providing deep insights into diabetes management.

8+ partners

Research Partners

Collaborating with leading academic institutions worldwide to advance diabetes research and innovation.

100% consent

User Consent

All data is collected with explicit user consent, ensuring privacy and ethical research practices.

Our Solutions

Syntactiq.ai provides a comprehensive platform that combines data collection, storage, and AI-powered analytics to accelerate research and innovation in diabetes care.

Syno AI application interface

Syno AI Icon Syno: AI-Powered Analytics

Our specialized multi-agent network of Large Language Models analyzes complex diabetes data and research questions, reducing research timelines from months to days.

  • Advanced pattern recognition across diverse data types
  • Rapid hypothesis testing and validation
  • Natural language interfaces for complex queries
  • Actionable insights for researchers and product developers

Cockpit App Icon Diabetes Cockpit App

Our user-friendly mobile application helps patients monitor and track their diabetes data while contributing to groundbreaking research with full consent and anonymization.

  • Comprehensive tracking for glucose levels, insulin, activity, and more
  • Intuitive visualizations to help users understand their patterns
  • Secure, private data collection with full user consent
  • Personalized insights to improve diabetes management
Diabetes Cockpit exploded view

Our Data

We've collected a rich, comprehensive dataset that provides unprecedented insights into diabetes management, with full user consent and anonymization.

Glucose Monitoring

Comprehensive continuous glucose monitoring data capturing daily patterns, fluctuations, and responses to various factors.

550,000+ days

Physical Activity

Detailed physical activity tracking including exercise type, duration, intensity, and impact on glucose levels.

500,000+ days

Heart Rate Data

Continuous heart rate monitoring providing insights into cardiovascular health and its relationship with diabetes management.

125,000+ days

Insulin Dosing

Detailed tracking of insulin administration patterns, including timing, dosage, and response effects.

200,000+ days

Nutrition Data

Comprehensive meal logging with detailed carbohydrate tracking, and glycemic impact analysis.

220,000+ days

Sleep Tracking

In-depth sleep pattern analysis including duration, and correlation with glucose levels.

200,000+ nights

Body Weight Data

Comprehensive tracking of body weight changes and their impact on diabetes management and treatment outcomes.

100,000+ days

Menstruation Data

Detailed tracking of menstrual cycles and their correlation with glucose levels and insulin sensitivity.

800+ months

Demographics Data

Comprehensive user profiles including diabetes type, age, country, therapy setup, gender, and other relevant demographic information.

3,000+ profiles

People We Work With

Hear from our research partners about their experience working with Syntactiq.ai

"... an invaluable resource for advancing closed-loop system research, offering access to data and tools that can help us drive innovation and outcomes in diabetes management."

PD Dr. med Martin Tauschmann

PD Dr. med Martin Tauschmann

Medical University of Vienna, Austria

"With the Diabetes Cockpit dataset and tools offered by Syntactiq, we have new avenues for understanding the intricate relationship between activity, exercise, and diabetes management, driving innovation in personalized care."

Prof. Othmar Moser

Prof. Othmar Moser

University of Bayreuth, Germany

"Syntactiq.ai's sleep data is a game-changer for understanding how sleep impacts diabetes management, especially for personalized care."

PD Dr. med. Katarina Braune

PD Dr. med. Katarina Braune

Medical University Charité, Germany

"Answering key questions in diabetes is often hard due to lack of data. Working with Lukas has been the opposite — rich context, open sharing, and a friendly, accessible team. We're truly excited to work with such a unique resource."

Peter Senior

Peter Senior

University of Alberta, Canada

"Syntactiq's vast real-world dataset on insulin and glucose is enabling us to explore new approaches and develop algorithms in ways that were previously inaccessible to us."

Samuel King

Samuel King

University of California, Davis, USA

Our Partners

We collaborate with leading industry and academic institutions to accelerate innovation and research in diabetes care.

Industry Partners

Coming soon partner 1
OneTwenty logo

OneTwenty

Digital health innovator specializing in diabetes management solutions.

Switzerland
Coming soon partner 3

Academic Collaborators

University of Alberta logo

University of Alberta

Renowned for its AI and health sciences research, this leading Edmonton university drives global innovation.

Canada
University of California, Davis logo

University of California, Davis

A top-tier public research university solving global challenges through comprehensive academic programs and innovation.

USA
King's College London logo

King's College London

Esteemed London research institution, globally recognized for impactful work in health sciences and diabetes research.

UK
Medical University of Vienna logo

Medical University of Vienna

One of Europe's most prestigious medical institutions, highly focused on cutting-edge research and advancing medical science.

Austria
Medical University of Graz logo

Medical University of Graz

Historic institution renowned for socially relevant medical research, fostering international collaboration and innovation.

Austria
Charité Hospital Berlin logo

Charité Hospital Berlin

One of Europe's largest university hospitals, celebrated for excellence in medical research, patient care, and pioneering sleep medicine.

Germany
University of Bayreuth logo

University of Bayreuth

A dynamic research-oriented campus university known for its interdisciplinary approach and strong focus on sustainability.

Germany
University of Girona logo

University of Girona

Public institution committed to teaching and research excellence, with a distinct emphasis on science, technology, and engineering.

Spain

About Syntactiq

We're dedicated to transforming diabetes research through innovative technology and data-driven insights.

Symbolic image representing Syntactiq.ai's mission

Our Mission

At Syntactiq.ai, we're committed to significantly advancing diabetes research and product development by addressing critical data access and analysis challenges. We believe that with the right data and tools, we can accelerate breakthroughs in diabetes care.

Our approach centers on three core principles:

  • Ethical Data Collection: All data is gathered with full user consent and proper anonymization.
  • Innovative Technology: Leveraging AI and advanced analytics to extract meaningful insights.
  • Collaborative Research: Partnering with industry leaders and academic institutions to drive innovation.

Meet Our Team

Syntactiq's leadership team consists of exceptionally senior Type 1 diabetes industry veterans, bringing a combined experience of over 40 years to the company. Their proven expertise, honed through leadership roles at major diabetes care organizations and successfully scaling ventures, comprehensively covers advanced data architecture, AI product development, regulatory compliance, and strategic commercial leadership.

Lukas Schuster - Technology & Product

Lukas Schuster

Technology & Product

Co-founder & CEO, Lukas brings in over 10 years of industry experience and a mix of technology and product gathered at mySugr and Roche Diabetes Care.

Fredrik Debong - Quality and Compliance

Fredrik Debong

Quality and Compliance

Co-founder Fred guides our regulatory, compliance, & quality strategy. A mySugr co-founder, he brings deep industry experience & a vast diabetes network.

Richard Laurits - Advisor for Commercial

Richard Laurits

Advisor for Commercial

Richard advises on commercial strategy. With senior leadership experience at Diasend & Glooko, he provides a robust industry network & strategic direction.

Marc Grüner - Data Science and Engineering

Marc Grüner

Data Science and Engineering

Marc is the driving force behind Syno and brings expertise in data science and clinical statistics from his background in research.

Get in Touch

Ready to accelerate your diabetes research or product development? Connect with us to learn more about our data platform and AI-powered analytics.

Contact Information

Location

Vienna, Austria